Paying user area
Try for free
Thermo Fisher Scientific Inc. pages available for free this week:
- Income Statement
- Statement of Comprehensive Income
- Common-Size Income Statement
- Analysis of Profitability Ratios
- Analysis of Liquidity Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Price to FCFE (P/FCFE)
- Dividend Discount Model (DDM)
- Return on Equity (ROE) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Thermo Fisher Scientific Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Operating income1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | = | ÷ | = | ÷ | |||||||
| Feb 20, 2025 | = | ÷ | = | ÷ | |||||||
| Feb 22, 2024 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2023 | = | ÷ | = | ÷ | |||||||
| Feb 24, 2022 | = | ÷ | = | ÷ | |||||||
| Feb 25, 2021 | = | ÷ | = | ÷ | |||||||
| Feb 26, 2020 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2019 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2018 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2017 | = | ÷ | = | ÷ | |||||||
| Feb 25, 2016 | = | ÷ | = | ÷ | |||||||
| Feb 26, 2015 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2014 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2013 | = | ÷ | = | ÷ | |||||||
| Feb 29, 2012 | = | ÷ | = | ÷ | |||||||
| Feb 24, 2011 | = | ÷ | = | ÷ | |||||||
| Feb 26, 2010 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2009 | = | ÷ | = | ÷ | |||||||
| Feb 29, 2008 | = | ÷ | = | ÷ | |||||||
| Mar 1, 2007 | = | ÷ | = | ÷ | |||||||
| Mar 2, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Thermo Fisher Scientific Inc. Annual Report.
The Price to Operating Profit (P/OP) ratio for the analyzed period exhibits considerable fluctuation, though generally trends upward over the long term. Initial values are relatively low, followed by periods of significant increase and subsequent stabilization, with a recent slight decline. The ratio’s behavior appears correlated with both share price and operating profit per share movements.
- Initial Period (2006-2009)
- The P/OP ratio begins at 21.48 in 2006 and experiences a substantial increase to 79.09 in 2007, driven primarily by a significant rise in share price relative to operating profit per share. This is followed by a decrease to 12.33 in 2009, coinciding with a decline in share price. Operating profit per share also shows volatility during this period, contributing to the ratio’s fluctuations.
- Stabilization and Growth (2010-2017)
- From 2010 through 2017, the P/OP ratio demonstrates a more stable, generally increasing trend. It moves from 19.04 to 28.24. This period is characterized by consistent growth in both share price and operating profit per share, though the share price increases at a faster rate. The ratio remains within a relatively narrow range, suggesting a balanced relationship between price and profitability.
- Recent Trends (2018-2026)
- Between 2018 and 2026, the P/OP ratio shows further increases, peaking at 31.16 in 2023, before declining slightly to 24.94 in 2026. The period from 2018 to 2021 sees substantial growth in operating profit per share, contributing to a lower, but still elevated, P/OP ratio. The share price also increases significantly during this time. The recent decline in the ratio in 2024 and 2025 is attributable to a decrease in share price, while operating profit per share remains relatively stable.
- Overall Observations
- The P/OP ratio demonstrates sensitivity to changes in both share price and operating profit per share. Periods of rapid share price increases, such as 2007 and 2021, lead to higher ratios. Conversely, declines in share price, as seen in 2009, result in lower ratios. The ratio’s long-term trend suggests increasing investor confidence in the company’s ability to generate profits, though recent fluctuations warrant continued monitoring.
Comparison to Competitors
| Thermo Fisher Scientific Inc. | AbbVie Inc. | Amgen Inc. | Danaher Corp. | Gilead Sciences Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | |||||||
| Feb 20, 2025 | |||||||
| Feb 22, 2024 | |||||||
| Feb 23, 2023 | |||||||
| Feb 24, 2022 | |||||||
| Feb 25, 2021 | |||||||
| Feb 26, 2020 | |||||||
| Feb 27, 2019 | |||||||
| Feb 28, 2018 | |||||||
| Feb 28, 2017 | |||||||
| Feb 25, 2016 | |||||||
| Feb 26, 2015 | |||||||
| Feb 27, 2014 | |||||||
| Feb 27, 2013 | |||||||
| Feb 29, 2012 | |||||||
| Feb 24, 2011 | |||||||
| Feb 26, 2010 | |||||||
| Feb 27, 2009 | |||||||
| Feb 29, 2008 | |||||||
| Mar 1, 2007 | |||||||
| Mar 2, 2006 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).